EU approves two sites for making Pfizer's COVID-19 vaccine

Approving a ready-to-use formulation of the coronavirus shot

  
Image used for illustrative purpose Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021.

Image used for illustrative purpose Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021.

REUTERS/Dado Ruvic/Illustration

Europe's drug regulator said on Monday it has approved two more manufacturing sites for producing the COVID-19 vaccine developed by Pfizer Inc, while also approving a ready-to-use formulation of the coronavirus shot.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta) ((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile: +91 852 751 3793))


More From Life